search icon

    Market Snapshot

    • S&P Futures

      4,132.75

    • Dow Futures

      32,794

    • Nasdaq Futures

      13,103.75

    blog search icon

    Amryt Pharma plc

    (NASDAQ:AMYT)

    $7.87

    -

    -

    Amryt Pharma plc Chart

    AMYT Stock Price Today

    Amryt Pharma plc (AMYT) stock declined over - intraday to trade at $7.87 a share on NASDAQ. The stock opened with a gain of 3.15% at $7.87 and touched an intraday high of $8.17, rising 0.00% against the last close of $7.87. The stock went to a low of $7.807 during the session.

    Stock Snapshot

    $7.87

    Prev. Close

    620.79 Million

    Market Cap

    $7.807

    Day Low

    $7.87

    Open

    64.16 Million

    Number of Shares

    $8.17

    Day High

    -

    P/E ratio

    -0.17

    EPS (TTM)

    1.59

    Cash Flow per Share

    0.34

    Free Float in %

    4.83

    Book Value

    57,285

    Volume

    Amryt Pharma plc Historical Data

    DateOpenHighLowCloseVolume
    2022-08-08$7.87$8.17$7.807$7.8757,285
    2022-08-05$7.63$8.056$7.63$7.8726,500
    2022-08-04$7.11$7.86$7.11$7.7756,700
    2022-08-03$7.419$7.459$7.36$7.415,000
    2022-08-02$7.43$7.43$7.15$7.4151,900
    2022-08-01$7.34$7.59$7$7.35559,000
    2022-07-29$7.41$7.52$7.24$7.2645,000
    2022-07-28$7.485$7.575$7.39$7.4928,200
    2022-07-27$7.35$7.535$7.35$7.4716,600
    2022-07-26$7.35$7.575$7.32$7.4140,500

    Contact Details

    45 Mespil Road
    Dublin 4
    Ireland

    Webiste:AMYT

    353 1 518 0200

    Company Information

    Employees-

    Beta-

    Sales or Revenue233.24 Million

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryPharmaceuticals

    About Company

    Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the rare cholesterol disorder. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.

    Frequently Asked Questions

    icon

    What is the current Amryt Pharma plc (AMYT) stock price?

    Amryt Pharma plc (NASDAQ: AMYT) stock price is $7.87 as of the last check on Monday, August 8. During the trading session, AMYT stock reached the peak price of $8.17 while $7.807 was the lowest point it dropped to.

    icon

    AMYT's industry and sector of operation?

    The NASDAQ listed AMYT is part of Pharmaceuticals industry that operates in the broader Health Care sector. Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the rare cholesterol disorder.

    icon

    Who are the executives of AMYT?

    Mr. Stephen Joyce
    VP of Global Marketing
    Dr. Mark Sumeray FRCS, M.D., M.S.
    Chief Medical Officer
    Dr. Joseph A. Wiley
    CEO & Director
    Mr. Rory P. Nealon
    CFO, COO & Company Sec.

    icon

    What is the AMYT stock price today?

    AMYT stock traded closed the last session at $7.87, which is $0 or 0% lower than its previous close of $7.87. AMYT's current trading price is 40.29% lower than its 52-week high of $12.45 where as its distance from 52-week low of 5.61% is -36.79%.

    icon

    How many employees does AMYT have?

    Number of AMYT employees currently stands at -. AMYT operates from 45 Mespil Road, Dublin 4, Ireland.

    icon

    Link for AMYT official website?

    Official Webiste of $AMYT is: https://www.amrytpharma.com

    icon

    How do I contact AMYT?

    AMYT could be contacted at AMYT operates from 45 Mespil Road, Dublin 4, Ireland, or at phone #353 1 518 0200 and can also be accessed through its website.

    icon

    How many shares of AMYT are traded daily?

    AMYT stock volume for the day was 57,285 shares while in the previous session number of AMYT shares traded was 57,285 . The average number of AMYT shares traded daily for last 3 months was 78 Thousands.

    icon

    How much did AMYT change today?

    The percentage change in AMYT stock occurred in the recent session was 0% while the dollar amount for the price change in AMYT stock was $0.

    icon

    What price range AMYT stock been trading in?

    In the recent session, the day high for AMYT stock was $8.17 while the low for AMYT stock touched on the day was $7.807.

    icon

    What is the market cap of AMYT currently?

    The market value of AMYT currently stands at 620.79 Million with its latest stock price at $7.87 and 64.16 Million of its shares outstanding.